CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Tonix Pharmaceuticals Holding Corp. - TNXP CFD

0.40
5.26%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 0.38
Open 0.39
1-Year Change -2.5%
Day's Range 0.39 - 0.4
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 3, 2024 0.40 0.01 2.56% 0.39 0.40 0.39
Jan 2, 2024 0.38 0.00 0.00% 0.38 0.40 0.37
Dec 28, 2023 0.38 -0.01 -2.56% 0.39 0.39 0.38
Dec 27, 2023 0.39 0.00 0.00% 0.39 0.39 0.39
Dec 26, 2023 0.38 0.00 0.00% 0.38 0.38 0.38
Dec 21, 2023 0.38 -0.02 -5.00% 0.40 0.40 0.38
Dec 20, 2023 0.39 -0.22 -36.07% 0.61 0.64 0.38
Dec 19, 2023 0.58 -0.08 -12.12% 0.66 0.66 0.51
Dec 18, 2023 0.65 0.07 12.07% 0.58 0.66 0.57
Dec 15, 2023 0.56 0.05 9.80% 0.51 0.56 0.50
Dec 14, 2023 0.50 0.09 21.95% 0.41 0.50 0.41
Dec 13, 2023 0.40 0.01 2.56% 0.39 0.40 0.39
Dec 12, 2023 0.39 0.01 2.63% 0.38 0.39 0.38
Dec 11, 2023 0.38 -0.01 -2.56% 0.39 0.39 0.38
Dec 8, 2023 0.38 0.00 0.00% 0.38 0.39 0.38
Dec 7, 2023 0.39 -0.04 -9.30% 0.43 0.43 0.39
Dec 6, 2023 0.44 -0.03 -6.38% 0.47 0.47 0.40
Dec 5, 2023 0.45 -0.02 -4.26% 0.47 0.48 0.45
Dec 4, 2023 0.45 -0.06 -11.76% 0.51 0.53 0.44
Dec 1, 2023 0.50 0.00 0.00% 0.50 0.50 0.49

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Tonix Pharmaceuticals Holding Corp. Company profile

Tonix Pharmaceuticals Holding Corp. (TNXP) is a clinical-stage biopharmaceutical company that focuses on understanding diseases and developing innovative therapies with the potential to address unmet needs. 

Headquartered in Chatham, New Jersey, Tonix Pharma was founded in 2007 with the idea of developing a diverse yet curated portfolio of small molecule drugs across various therapeutic areas, like the central nervous system (CNS), immunology, infectious disease and rare diseases. With a significant investment in in-house research and development and manufacturing, Tonix Pharma accelerates the drug development and reachability timeline and can respond immediately in case of an infectious disease breakout. 

The company’s CNS portfolio comprises TNX-102 SL (Confirmatory Phase 3) for Fibromyalgia. Drugs in phase 2 development are TNX-102 SL for Posttraumatic Stress Disorder (PTSD), TNX-102 SL for long Covid, TNX-1300 for cocaine overdose and TNX-1900 for chronic migraine. It also has two drugs in the preclinical phase: TNX-1500 for organ transplant rejection/autoimmune disorders and TNX-1700 for gastric and colorectal cancers. 

Pathogenic infections like smallpox and monkeypox have been a core area of focus for Tonix for a long time, however, the Covid-19 outbreak pushed the company to focus on rapid preparedness to combat infectious diseases. The company has the TNX-1840/1850 Covid-19 vaccine, TNX-3500 Covid-19 antiviral, TNX-3600 Covid-19 therapeutic and TNX-801 smallpox and monkeypox vaccine under development and in preclinical stages. 

Tonix’s rare disease portfolio includes TNX-2900 for Prader-Willi syndrome, which is in the preclinical stage.

Tonix shares began trading under the ticker symbol ‘TNXP’ on the Nasdaq Capital Market in August 2013.

Industry: Bio Therapeutic Drugs

26 Main Street, Suite 101
CHATHAM
NEW JERSEY 07928
US

News

UK CPI Preview: Will inflation return to 2% as the BoE predicts? And how will it affect GBP?

The latest round of inflation data will be released at 22 April at 7 am BST and investors are likely going to be paying close attention.

15:44, 21 May 2024

Reserve Bank of New Zealand Preview: RBNZ could become more dovish as inflation eases and growth softens

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, May 22, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

15:29, 21 May 2024

Nvidia Q1 Earnings Preview: Analysts forecast another blockbuster set of results

Nvidia (NVDA) reports its Q1 results after the closing bell on Wednesday, May 22nd. We preview what to expect from Nvidia’s earnings and analyse its stock's technicals.

14:57, 21 May 2024
CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

Stock market crash: how far can the S&P 500 go?

After a remarkably strong first quarter, the US stock market pulled back in April for the first time since October last year.

11:46, 10 May 2024

Bank of England preview: possible rate cut in summer?

The Bank of England (BoE) is widely expected to keep interest rates unchanged when it meets later this week. Data from Reuters shows a 90% chance of no change to the current rate of 5.25%, but the central bank will need to decide whether to change the messaging about rate cuts this year as traders will be paying close attention to any rate-cut clues.

12:39, 8 May 2024

We’re partnering with Newsquawk

Filter out the noise and focus on the news that matters.

08:32, 23 April 2024

People also watch

Gold

2,421.90 Price
-0.130% 1D Chg, %
Long position overnight fee -0.0194%
Short position overnight fee 0.0112%
Overnight fee time 21:00 (UTC)
Spread 0.31

XRP/USD

0.55 Price
+1.420% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

69,724.05 Price
0.000% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

ETH/USD

3,741.80 Price
+6.790% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading